GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Selling and Marketing Expense

Haleon (Haleon) Selling and Marketing Expense : $0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Haleon's Selling and Marketing Expense for the three months ended in Mar. 2024 was $0 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 was $0 Mil.

Haleon Selling and Marketing Expense Historical Data

The historical data trend for Haleon's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Selling and Marketing Expense Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
- - - - -

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Haleon Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleon Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Haleon's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (Haleon) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Selling and Marketing Expense
Comparable Companies
LSE:HIK LSE:HCM LSE:INDV LSE:BMK LSE:APH LSE:ANCR LSE:EAH LSE:AGY LSE:CEL LSE:STX ZTS XTER:MRK TSE:4502 NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NBIX
Traded in Other Exchanges
HLNCF:USA HLN1:Mexico HLNl:UK HLN:UK H6D0:Germany
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Website
https://www.haleon.com
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.